Literature DB >> 19924133

Possible roles of IL-27 in the pathogenesis of psoriasis.

Sayaka Shibata1, Yayoi Tada, Naoko Kanda, Kiyoko Nashiro, Masahiro Kamata, Masaru Karakawa, Tomomitsu Miyagaki, Hiromichi Kai, Hidehisa Saeki, Yuji Shirakata, Shinichi Watanabe, Kunihiko Tamaki, Shinichi Sato.   

Abstract

The immunological significance of IL-27 has been reported and discussed in various Th1/Th17-mediated inflammatory diseases. However, its importance in psoriasis is unknown. We investigated pathophysiological roles of IL-27 in psoriasis in this study. Serum IL-27 levels in psoriatic patients were significantly higher than those in healthy controls, and correlated with disease severity and serum IFN-gamma levels. An immunohistochemical analysis revealed the infiltration of IL-27-secreting cells in the papillary dermis of psoriatic skin lesions but not in skin lesions with atopic dermatitis or normal skin. Furthermore, IL-27 alone greatly induced in vitro CXCL9, CXCL10, and CXCL11 production and tyrosine phosphorylation of signal transducer and activator of transcription 1 in normal human keratinocytes, while it suppressed the tumor necrosis factor-alpha-induced production of IL-1alpha and CCL20. These results indicate that IL-27 may promote the onset of psoriasis, while it may simultaneously attenuate the expanded inflammation in this disease. Our results implicate potential therapeutic effects of IL-27 for psoriasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19924133     DOI: 10.1038/jid.2009.349

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  27 in total

1.  Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27.

Authors:  George D Kalliolias; Rachael A Gordon; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

Review 2.  Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.

Authors:  Ya-Chu Tsai; Tsen-Fang Tsai
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-11-06       Impact factor: 5.346

3.  Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages.

Authors:  Jana Zeitvogel; Alexander Dalpke; Britta Eiz-Vesper; Michael Kracht; Oliver Dittrich-Breiholz; Thomas Werfel; Miriam Wittmann
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 4.  Modulation of inflammation by interleukin-27.

Authors:  Markus Bosmann; Peter A Ward
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

5.  Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.

Authors:  Wendy A Goodman; Andrew B Young; Thomas S McCormick; Kevin D Cooper; Alan D Levine
Journal:  J Immunol       Date:  2011-02-09       Impact factor: 5.422

Review 6.  A cutting edge overview: psoriatic disease.

Authors:  Siba P Raychaudhuri
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 7.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

Review 8.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

9.  Decreased serum interleukin 27 in Brazilian systemic lupus erythematosus patients.

Authors:  Angela Luzia Branco Pinto Duarte; Andréa Tavares Dantas; Henrique de Ataíde Mariz; Flaviana Alves dos Santos; Juliana Cruz da Silva; Laurindo Ferreira da Rocha; Suely Lins Galdino; Maira Galdino da Rocha Pitta
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

10.  IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation.

Authors:  Fabio Morandi; Emma Di Carlo; Soldano Ferrone; Andrea Petretto; Vito Pistoia; Irma Airoldi
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.